Evidence map›Paper›PMID 22089637›Full record

ReviewJournal of bioenergetics and biomembranes2011

Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS.

Ellen F Barrett, John N Barrett, Gavriel David

Abstract readReview
In one paragraph

Review in Journal of bioenergetics and biomembranes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Targeting mitochondrial CaThe Journal of physiology · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. SOD2 in mitochondrial dysfunction and neurodegeneration.Free radical biology & medicine · 2013
    Review
  12. Article
  13. Article
  14. Mitochondria, calcium-dependent neuronal death and neurodegenerative disease.Pflugers Archiv : European journal of physiology · 2012
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ellen F BarrettDepartment of Physiology and Biophysics, R-430, University of Miami Miller School of Medicine, Miami, FL 33136, USA. ebarrett2@med.miami.edu
John N Barrett
Gavriel David
University of Miami · US

Funding

Ca2+ mishandling and ischemia-vulnerability in fALS model motor terminalsR01NS058888 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DAVID, GAVRIEL · 2008 to 2012
$1.4M
NINDS NIH HHS R01 NS058888PHS HHS R01 12404PHS HHS R01 58888
6 · The paper itself

Abstract

Mitochondria contribute to neuronal function not only via their ability to generate ATP, but also via their ability to buffer large Ca(2+) loads. This review summarizes evidence that mitochondrial Ca(2+) sequestration is especially important for sustaining the function of vertebrate motor nerve terminals during repetitive stimulation. Motor terminal mitochondria can sequester large amounts of Ca(2+) because they have mechanisms for limiting both the mitochondrial depolarization and the increase in matrix free [Ca(2+)] associated with Ca(2+) influx. In mice expressing mutations of human superoxide dismutase -1 (SOD1) that cause some cases of familial amyotrophic lateral sclerosis (fALS), motor terminals degenerate well before the death of motor neuron cell bodies. This review presents evidence for early and progressive mitochondrial dysfunction in motor terminals of mutant SOD1 mice (G93A, G85R). This dysfunction would impair mitochondrial ability to sequester stimulation-associated Ca(2+) loads, and thus likely contributes to the early degeneration of motor terminals.

Indexed as

Amino Acid SubstitutionAmyotrophic Lateral SclerosisAnimalsCalciumDisease Models, AnimalGenetic Diseases, InbornHumansMiceMice, TransgenicMitochondriaMotor EndplateMotor NeuronsMutationMutation, MissenseSuperoxide DismutaseSuperoxide Dismutase-1CalciumSOD1 protein, humanSod1 protein, mouseSuperoxide DismutaseSuperoxide Dismutase-1

Identifiers

PMID22089637
PMCPMC3237816
OpenAlexW2118801811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.